Enhancer ID: | E_01_0917 |
Species: | human |
Position : | chr17:72118080-72120080 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Colon cancer |
Pubmed ID: | 32308428 |
Enhancer experiment: | Western blot,viability assay, colony formation assay, scratch wound healing assay |
Enhancer experiment description: | Lymphoid enhancer-binding factor 1 antisense RNA 1 (LEF1-AS1), a highly conserved and newly discovered long non-coding RNA, has been reported to be upregulated and correlated with poor prognosis in colon cancer, but the exact role of it remains uncertain. |
Target gene : | LEF1-AS1 |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Lymphoid enhancer-binding factor 1 antisense RNA 1 (LEF1-AS1), a highly conserved and newly discovered long non-coding RNA, has been reported to be upregulated and correlated with poor prognosis in colon cancer, but the exact role of it remains uncertain.;Lymphoid enhancer-binding factor 1 antisense RNA 1 (LEF1-AS1), a highly conserved and newly discovered long non-coding RNA, has been reported to be upregulated and correlated with poor prognosis in colon cancer, but the exact role of it remains uncertain. |
TF name : | SOX9(CMD1,CMPD1,SRA1,SRXX2,SRXY10) |
TF experiment: | Western blot,viability assay, colony formation assay, scratch wound healing assay |
TF experiment description: | Lymphoid enhancer-binding factor 1 antisense RNA 1 (LEF1-AS1), a highly conserved and newly discovered long non-coding RNA, has been reported to be upregulated and correlated with poor prognosis in colon cancer, but the exact role of it remains uncertain.;Lymphoid enhancer-binding factor 1 antisense RNA 1 (LEF1-AS1), a highly conserved and newly discovered long non-coding RNA, has been reported to be upregulated and correlated with poor prognosis in colon cancer, but the exact role of it remains uncertain. |
Enhancer function : | Lymphoid enhancer-binding factor 1 antisense RNA 1 (LEF1-AS1), a highly conserved and newly discovered long non-coding RNA, has been reported to be upregulated and correlated with poor prognosis in colon cancer, but the exact role of it remains uncertain. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Lymphoid enhancer-binding factor 1 antisense RNA 1 (LEF1-AS1), a highly conserved and newly discovered long non-coding RNA, has been reported to be upregulated and correlated with poor prognosis in colon cancer, but the exact role of it remains uncertain. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|---|---|---|
SOX9 | Deactivation of the beta-catenin transactivating complex | reactome | 42 |
SOX9 | TGF_beta_Receptor | netpath | 220 |
SOX9 | Hs_Neural_Crest_Differentiation_WP2064_79263 | wikipathways | 40 |
SOX9 | Hs_Spinal_Cord_Injury_WP2431_87678 | wikipathways | 21 |